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Objectives. The aim of this study was to assess the tolerability
and incremental diagnostic value of high adenosine doses in stress
echocardiography testing in patients with coronary artery disease
(CAD).
Background. In comparison with other pharmacologic stress
echocardiography tests, standard dose adenosine stress has sub-
optimal sensitivity for detecting milder forms of CAD.
Methods. Adenosine stress echocardiography was performed in
58 patients using a starting dose of 100 g/kg body weight per min
over 3 min followed by 140 g/kg per min over 4 min (standard
dose). If no new wall motion abnormality appeared, the dose was
increased to 200 g/kg per min over 4 min (high dose). All
patients underwent coronary angiography. Signiﬁcant CAD was
deﬁned as >50% diameter stenosis in at least one major coronary
artery. Thirty-three patients had one-vessel and seven had mul-
tivessel CAD. Coronary angiographic ﬁndings were normal in 18
patients.
Results. The high adenosine dose caused a slight but signiﬁcant
increase over baseline values in rate-pressure product. Limiting
side effects occurred in two patients during the standard dose
protocol and in one patient receiving the high dose regimen. The
test was stopped in 30 patients after the standard adenosine dose
regimen because of a provoked new wall motion abnormality. The
sensitivity of adenosine echocardiography with the standard dose
was 75% (95% conﬁdence interval [CI] 63% to 87%). After
completion of the standard dose protocol, 28 patients continued
testing with the high dose adenosine protocol. The overall sensi-
tivity of adenosine echocardiography, calculated as cumulative,
increased to 92% (95% CI 84% to 100%) with the high dose (p <
0.05). The speciﬁcity of adenosine testing was 100% and 88%,
respectively, with the standard and high dose regimen (p 0.617).
Conclusions. We believe that use of a higher than usual
adenosine dose protocol for stress testing may improve the
diagnostic value of adenosine echocardiography, mainly by in-
creasing sensitivity in patients with single-vessel disease without
deterioration of the safety proﬁle and with only a mild reduction
in speciﬁcity.
(J Am Coll Cardiol 1996;28:1689–95)
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The infusion protocol for pharmacologic stress echocardiogra-
phy has evolved rapidly in recent years, with more aggressive
dosing providing greater sensitivity for noninvasive detection
of coronary artery disease (CAD) than that achieved with the
standard, more conservative dose regimen. This dose-
dependent increase in sensitivity has been shown for dipyrid-
amole (1,2) and dobutamine (3,4), the two most popular stress
tests. The sensitivity of dipyridamole increased from 53%
with a dose of 0.56 mg/kg body weight over 4 min to 74%
with a dose of 0.84 mg/kg over 10 min (2). The ischemic
potential of dobutamine increased when the infusion dose was
increased from 20 to 40 g/kg per min (3).
Similar changes might be expected to occur with increased
dosage in adenosine stress testing. With the current standard
dose regimen (140 g/kg per min), the main limitation of the
adenosine stress test is its less than ideal sensitivity in patients
with anatomically milder forms of CAD (5,6). We speculated
that in analogy with other forms of pharmacologic stress
testing, greater sensitivity might be achieved with more aggres-
sive adenosine dosing.
Because the magnitude of changes in the coronary circula-
tion depends, among other factors, on the dose of the coronary
vasodilator used (7), we performed standard adenosine stress
echocardiography in 58 patients scheduled for coronary an-
giography. In all patients with an echocardiographically nega-
tive well tolerated standard dose test, we prolonged the test
with a higher adenosine infusion rate—200 g/kg per min—the
so-called high dose adenosine echocardiography test.
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Methods
Study patients. Between January 1993 and May 1994, 58
patients (51 men, 7 women; mean age 50  9 years) scheduled
for coronary angiography were enrolled in the study. None had
congestive heart failure, unstable angina, severe congenital or
valvular heart disease or documented cardiomyopathy. Pa-
tients with severe hypertension (systolic pressure200 mm Hg
and diastolic pressure 120 mm Hg), recent malignant ven-
tricular arrhythmias, high degree atrioventricular (AV) block,
sick sinus syndrome and severe asthmatic or chronic obstruc-
tive pulmonary disease were excluded. The study was approved
by our institution’s human use committee, and informed
consent was obtained from all patients.
This was a prospective study in which each patient under-
went adenosine stress testing within 10 days of coronary
angiography. Of the 58 patients, 13 had had a previous non-Q
wave and 11 a Q wave myocardial infarction, 24 had angina
pectoris and 10 described atypical chest pain. Stress echocar-
diography was performed 14 days after infarction. The
diagnosis of acute myocardial infarction was based on the
presence of at least two of three criteria: typical symptoms
including severe chest pain lasting 30 min, unequivocal
electrocardiographic (ECG) ﬁndings of infarction and charac-
teristic rise and fall in plasma creatine kinase activity.
In 75% of patients, the clinically prescribed antianginal
medications (single or combined) were continued. These con-
sisted of nitrates in 39 patients, calcium channel antagonists in
21 and beta-adrenergic blocking agents in 19. Theophylline,
caffeine-containing products and dipyridamole preparations
were not allowed for 12 h before the test.
Stress protocols. The adenosine protocol consisted of in-
travenous adenosine infusion at a rate of 100 g/kg per min for
3 min followed by 140 g/kg per min for 4 min (standard dose).
Blood pressure, heart rate and ECG were monitored each
minute during adenosine infusion. In patients with negative
echocardiographic ﬁndings who tolerated well the regular
dose, the adenosine infusion rate was increased to 200 g/kg
per min over the next 4 min (Fig. 1).
The infusion was stopped before administration of the
maximal dose for any of the following reasons: obvious positive
echocardiographic ﬁndings, progressive and severe angina
accompanied by marked ST segment changes, symptomatic
hypotension (decrease in systolic blood pressure 20 mm Hg
accompanied by nausea, sweating, dizziness, etc.) or hyperten-
sion, severe ECG rhythm or conduction abnormalities or
intolerable symptoms.
ECG and echocardiographic monitoring. A 12-lead ECG
and blood pressure recordings were performed at baseline and
thereafter at the end of each stage of the adenosine stress
protocol or before premature cessation of the test. An ECG
tracing was considered diagnostic for myocardial ischemia in
the presence of ST segment horizontal or downsloping depres-
sion of at least 0.1 mV, 0.08 s after the J point. Rate-pressure
product was calculated by multiplying systolic blood pressure
and heart rate. Patients were asked to describe the symptoms
they experienced. All ECG results were reviewed without
knowledge of clinical data or results of echocardiographic or
angiographic ﬁndings.
Echocardiographic analyses. Two-dimensional echocardi-
ography was performed continuously before, during and after
adenosine infusion with the patient in the left lateral decubitus
position. At the end of each stage of the protocol, and when
new or worsening of preexisting wall motion abnormalities
developed, imaging was performed in the same views obtained
at baseline. After cessation of the test, echocardiographic
imaging was continued until hemodynamic variables or left
ventricular wall motion, or both, returned to the basal state. In
each patient apical (two-chamber, four-chamber and ﬁve-
chamber views) and parasternal long-axis and short-axis views
were obtained. All echocardiograms were performed by using
a commercially available imaging system (Toshiba SSH60A;
Diasonics). A stress echocardiography test was interpreted
from the off-line digitalized videotapes (ImageView, ATL).
The location of the echocardiographic images on the quad
screen at baseline and at the end of the standard and high
adenosine dose regimens was randomly assigned for nonbiased
interpretation. All studies were analyzed by two experienced
observers who had no knowledge of patient clinical data or
angiographic ﬁndings. When disagreement occurred on test
positivity (n  four tests), a third, more experienced observer
reviewed the study and his judgment was accepted. For the
purpose of analysis the left ventricular walls were classiﬁed
according to an 11-segment model (8): apex, proximal and
distal anterior septum, proximal and distal inferior septum,
Abbreviations and Acronyms
AV  atrioventricular block
CAD  coronary artery disease
CI  conﬁdence interval
ECG  electrocardiogram
WMSI  wall motion score index
Figure 1. Protocol of the adenosine echocardiography test. ECG 
electrocardiogram; 2D ECHO  two-dimensional echocardiography.
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proximal and distal anterior wall, proximal and distal lateral
wall and proximal and distal inferior wall. Segmental wall
motion was evaluated and scored according to the method of
the American Society of Echocardiography (9) as normal
(score  1), hypokinetic (score  2), akinetic (score  3) or
dyskinetic (score  4). A wall motion score index (WMSI) was
derived by dividing the sum of individual segment scores by the
number of interpreted segments. Inadequately visualized seg-
ments were not scored. A ﬁnal WMSI was derived for rest and
peak stress echocardiograms. A stress echocardiography test
result was considered positive when a new or worsening wall
motion abnormality was observed.
Coronary angiography and angiographic analyses. All pa-
tients underwent selective coronary angiography with the
Judkins or Sones technique within 10 days of stress echocar-
diography. Multiple views of each coronary artery were ob-
tained. After visual inspection of the coronary artery in all
views, we selected the frame with optimal clarity, showing the
lesion at maximal narrowing and the arterial silhouette in
sharpest focus, independent of cardiac cycle timing. The
images were digitized and analyzed with the quantitative
coronary angiography imaging system (MEDIS CMS, Nether-
lands) by an observer unaware of the patient clinical data and
echocardiographic results. Signiﬁcant coronary artery stenosis
was considered present when 50% diameter stenosis of at
least one major coronary artery was observed.
Statistical analyses. Data are expressed as mean value 
SD. Comparisons between groups for continuous data were
made with the Student t test. One-way analysis of variance was
used when appropriate. Sensitivity, speciﬁcity and accuracy
were calculated according to standard deﬁnitions. For the high
adenosine dose regimen these values were calculated as cumu-
lative. Dichotomous variables were compared by chi-square
(McNemar test for paired proportions). Where appropriate,
95% conﬁdence intervals (CI) were given. A p value0.05 was
considered statistically signiﬁcant.
Results
Rest echocardiography. Thirteen patients with previous
myocardial infarction had rest regional dyssynergy, whereas 45
patients had no wall motion abnormality at rest. The mean rest
WMSI was 1.07  0.14.
Safety and feasibility. During the standard dose protocol,
39% of the patients (23 of 58) experienced minor side effects
(headache, ﬂushing, dyspnea and shivering). The same symp-
toms were present in 35% of patients (10 of 28) in whom we
prolonged the test with the higher dose protocol (p  0.908 vs.
standard dose). All of these symptoms were well tolerated and
graded as mild.
During the standard protocol, two patients, with angio-
graphically proved CAD manifested third-degree AV block
simultaneously with echocardiographic signs of myocardial
ischemia during the last minute of infusion. These changes
resolved with termination of the infusion.
During the high dose protocol, the test was stopped in 1 of 28
patients during minute 11 (last minute of the protocol) because
second-degree AV block developed. This patient had negative
echocardiographic and angiographic ﬁndings. In two addi-
tional patients without signiﬁcant CAD, ﬁrst-degree AV block
occurred during minutes 9 and 10, respectively, of the test;
both patients had normal echocardiographic ﬁndings and
completed the full protocol. In all patients, the episodes of AV
block self-terminated after discontinuation of the infusion.
No major adverse events occurred with either the standard
or the high adenosine dose regimen. Overall feasibility for the
high adenosine dose protocol was 98%.
Hemodynamic changes. Heart rate, systolic blood pres-
sure, diastolic blood pressure and rate-pressure product are
reported in Table 1 for both the standard and high adenosine
dose regimens. Heart rate was signiﬁcantly higher than base-
line levels (p  0.01) during both regimens. Systolic and
diastolic blood pressure were slightly but insigniﬁcantly lower
than baseline levels with the standard dose regimen. The
decrease in systolic blood pressure from baseline during the
high dose regimen was of borderline statistical signiﬁcance
(p  0.054). The rate-pressure product was signiﬁcantly higher
at the end of the high dose adenosine protocol (p  0.05) as a
result of an increase in heart rate that outweighed the decrease
in blood pressure.
Echocardiographic, ECG and clinical ﬁndings. Interpret-
able echocardiograms were obtained for all patients, and no
patient was excluded because of a poor quality echocardio-
gram. Transient regional myocardial dysfunction occurred in
30 patients with the standard adenosine dose and in 7 patients
with the high dose regimen. Transient ECG changes (ST
Table 1. Hemodynamic Changes During Standard (140 g/kg per min) and High (200 g/kg per min)
Adenosine Stress Echocardiography Testing
Rest
1
Standard
Dose
2
High
Dose
3
p Value
1 vs. 2 1 vs. 3
SBP (mm Hg) 143 19 137  20 135  15 0.1 0.054
DBP (mm Hg) 85 11 81  13 81  7 0.07 0.054
HR (beats/min) 74 12 82  18 87  19 0.006 0.001
RPP/100 (mm Hg  beats/min) 105  23 113  33 117  27 0.13 0.035
WMSI 1.07  0.14 1.22  0.22 1.27  0.22 0.001 0.001
Data presented are mean value  SD. DBP  diastolic blood pressure; HR  heart rate; RPP  rate-pressure
product; SBP  systolic blood pressure; WMSI  wall motion score index.
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depression 1 mm) occurred in seven patients during the
standard dose regimen and in one patient during the high dose
infusion (p  NS vs. standard dose).
Angina pectoris was present in 14 (24%) of 58 patients
during the standard dose protocol and in an additional 8
patients who continued with the higher dose protocol (cumu-
lative 22 [38%] of 58, p  0.371 vs. standard dose).
Angiographic ﬁndings. Signiﬁcant CAD was present in 40
patients and absent in 18. Of the 40 patients with signiﬁcant
CAD, 9 had a previous Q wave and 13 a non-Q-wave myocar-
dial infarction, 17 had angina pectoris and 1 reported atypical
chest pain. One-vessel CAD was present in 33 patients,
two-vessel disease in 5 and three-vessel disease in 2. The
affected vessels were the left anterior descending coronary
artery in 34 patients, the circumﬂex branch of the left coronary
artery in 7 and the right coronary artery in 8. Collateral
circulation was present in 14 patients.
Comparison of adenosine stress and angiographic ﬁndings.
The sensitivity and speciﬁcity of standard and high dose
adenosine echocardiography, electrocardiography and the oc-
currence of chest pain are shown in Figure 2. The sensitivity of
adenosine echocardiography was 75% (95% CI 63% to 87%)
for the standard dose protocol and 92% (95% CI 84% to
100%) for the high dose protocol (p  0.05 vs. standard dose).
The speciﬁcity was 100% and 88%, respectively for the stan-
dard and the high dose regimen (p 0.617). Overall diagnostic
accuracy was 82% (95% CI 72% to 92%) for the standard
regimen and increased to 91% (95% CI 89% to 93%, p 0.01)
with the high dose regimen.
The sensitivity of adenosine echocardiography for detecting
one-vessel CAD improved from 75% (25 of 33) to 90% (30 of
33) with the high dose regimen (p  0.05 vs. standard dose).
The wall motion abnormalities seen in these patients always
corresponded to the territory of the affected coronary vessel.
We also found a signiﬁcant correlation between the maximal
tolerated duration of adenosine infusion without ischemia and
percent diameter stenosis (r0.60, p 0.01). The sensitivity
for detection of multivessel disease (present in seven patients)
was 71% (ﬁve of seven) and 100%, respectively, for the standard
and the high adenosine dose protocol (p  0.617). In patients
with signiﬁcant CAD, the WMSI increased from rest to peak
stress with the standard dose (1.22  0.22) and high dose
(1.27  0.22) adenosine regimens (p  0.01 vs. rest WMSI).
The sensitivity of adenosine echocardiography for detecting
left anterior descending CAD was 74% (25 of 34 patients) with
the standard dose and 91% with the high dose regimen
(cumulative 31 of 34, p  0.077 vs. standard dose). Zero and
one patient, respectively, had false positive ﬁndings with the
standard and the high dose protocol, yielding a corresponding
speciﬁcity of 100% and 94% for the left anterior descending
artery territory. For the circumﬂex branch of the left coronary
artery, adenosine echocardiography had a sensitivity of 57%
(four of seven) with the standard dose and 71% with the high
dose regimen (ﬁve of seven, p  NS vs. standard dose).
Speciﬁcity was 100% for both doses. For the right coronary
artery, sensitivity was 75% (six of eight) with the standard dose,
and one additional patient was discovered with the high dose
(sensitivity 87%, p  NS vs. standard dose). Zero and one
patient, respectively, had false positive ﬁndings with the stan-
dard and the high dose regimen, yielding a corresponding
speciﬁcity of 100% and 94% for the right coronary artery
territory (p  NS vs. standard dose). In one patient with
multivessel CAD, two distinct myocardial segments became
dyssynergic with the high dose regimen; these segments corre-
sponded to the territory of the affected vessels.
Two observers independently reviewed the adenosine echo-
cardiography tests, with an overall interobserver agreement of
96%. Interobserver agreement was 100% for detection of left
anterior descending artery disease with the standard and high
adenosine dose regimen, and 94% for speciﬁcity with the high
dose protocol. For the circumﬂex branch of the left coronary
artery, interobserver agreement was 100% and 80%, respec-
tively, for sensitivity with the standard and the high dose
regimen and 100% for speciﬁcity with both regimens. For the
right coronary artery, interobserver agreement was 83% for
sensitivity with the standard regimen and 100% with the high
dose regimen. Speciﬁcity was 100% and 94%, respectively, for
the standard and the high dose regimen. In addition, one
observer reviewed all studies twice. Intraobserver agreement
Figure 2. Bar graphs showing sensitivity (upper panel) and speciﬁcity
(lower panel) of two-dimensional echocardiography (ECHO), electro-
cardiography (ECG) and the occurrence of chest pain in patients
receiving the standard (white bars) and high (hatched bars) dose
adenosine infusion.
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for sensitivity in detection of left anterior descending coronary
artery disease was 96% with both regimens, and 100% and
94%, respectively, for speciﬁcity with the standard and the high
adenosine dose regimen. For the circumﬂex branch of the left
coronary artery, intraobserver agreement was 100% for sensi-
tivity and speciﬁcity with the standard dose regimen and 83%
for sensitivity and 100% for speciﬁcity with the high dose
regimen. For the right coronary artery, these values were 83%
and 100%, respectively for sensitivity with the standard and the
high adenosine dose regimen and 100% for speciﬁcity with
both regimens.
Discussion
More aggressive adenosine dosing provides better diagnos-
tic accuracy than does standard adenosine dosing when the end
point is myocardial ischemia, deﬁned as a transient dyssynergy
with two-dimensional echocardiography. This increased diag-
nostic accuracy is due to a higher sensitivity that occurs without
a signiﬁcant decrease in speciﬁcity. This initial experience did
not show any signiﬁcant serious adverse reaction with the high
adenosine dose, although minor side effects tended to be more
frequent with this dose.
Pathophysiologic mechanisms of ischemia during high
dose adenosine infusion. The effects of adenosine are medi-
ated through speciﬁc cell surface receptors. The magnitude of
these effects therefore depends on the extracellular concentra-
tion achieved. The optimal dose of adenosine for stress testing
has not been well established. Wilson et al. (10) showed that
intravenous infusion of adenosine at 140 g/kg per min caused
maximal coronary hyperemia in 84% of normal patients. These
investigators also observed a 30-s cyclic increase and decrease
in coronary blood ﬂow at lower doses, a ﬁnding that was
postulated to result from cyclic variations in the concentration
of adenosine in the blood perfusing the coronary arteries.
Furthermore, Lapeyre and Gibbons (11) reported the same
30-s cycle ﬂuctuation in symptoms and ECG changes in their
patient with CAD, and they suggested that infusion of adeno-
sine at a rate of 140 g/kg per min may provoke only
submaximal vasodilation and thus may diminish the sensitivity
of the stress test for detecting CAD.
The stronger ischemic stress imposed on the myocardium
by the high dose versus the standard dose adenosine protocol
might result from a greater increase in myocardial oxygen
demand or a greater reduction in oxygen supply, or both. The
peak rate-pressure product was indeed higher with the higher
dose regimen. Although this increase was slight, it might have
contributed to the production of myocardial ischemia and
could account for the recorded increase in sensitivity. The
modest rise in rate-pressure product with the high dose
regimen was mostly due to an increase in heart rate, whereas
systolic and diastolic blood pressure tended to decrease further
when the high dose regimen followed the standard dose
regimen. These ﬁndings suggest that the dose-related increase
in heart rate was due to a systemic vasodilation and reﬂex
tachycardia, but it could also be due to adenosine-mediated
activation of an autonomic reﬂex mechanism (12–14).
A second, more likely mechanism is a reduction in oxygen
supply. The ﬂuctuating or submaximal vasodilation observed
with the standard adenosine dose may be either in the artery
that supplies the zone directly, as suggested by Wilson et al.
(10), or in the arteries that supply collateral vessels, which
could produce a “steal” phenomenon (15). A further decrease
in driving pressure may lead to a proportional decrease in
blood ﬂow in vascular beds distal to coronary stenosis during
high dose adenosine–induced vasodilation. With higher doses
a more pronounced coronary vasodilation could be achieved,
alternatively facilitating inappropriate arteriolar vasodilation
and eventually leading to a steal phenomenon and subendo-
cardial hypoperfusion.
Clinical implications. The usefulness of adenosine stress
echocardiography has been limited to date by suboptimal
sensitivity. Cheirif and Zoghbi (16) reported that the sensitivity
of adenosine echocardiography was 50% in detection of single-
vessel coronary artery disease. Martin et al. (5) found that in
their study group adenosine echocardiography had a sensitivity
of 40% for detecting 50% diameter coronary artery stenosis.
Previous studies using a standard adenosine dose of 140 g/kg
per min found that sensitivity is higher in patients with more
severe disease. Kujacic et al. (17) reported an 85% sensitivity
of adenosine echocardiography in a study group of patients
with predominantly multivessel disease. In clinical trials using
adenosine in conjunction with nuclear imaging techniques, the
sensitivity for detection of ischemic heart disease varied from
80% to 92% (18,19). Zoghbi et al. (20) reported that the
overall sensitivity of adenosine echocardiography was 85% in
73 patients, 27 of whom had abnormal wall motion at rest;
sensitivity was 60% in patients with a normal baseline ECG. In
our study, the sensitivity for detecting CAD with the standard
adenosine dose of 140 g/kg per min was somewhat lower
(75%) because of a predominance of patients with single-
vessel disease.
Attempts have been made to overcome this limitation of
reduced sensitivity in patients with less severe disease by
combining adenosine infusion with a stress increasing myocar-
dial oxygen demand, such as isometric handgrip exercise (21).
Tawa et al. (21) reported that in patients without previous
infarction, the sensitivity of adenosine echocardiography in-
creased from 64% to 81% with the addition of handgrip
exercise. However, with this addition the test becomes depen-
dent on patient motivation and ability to perform isometric
exercise. The high dose regimen perhaps presents a more
practical solution, allowing a higher sensitivity to be reached in
the same setting of pharmacologic testing, without any appar-
ent deterioration in safety proﬁle and only a slight decrease in
feasibility.
Few data are available on the use of a high dose adenosine
protocol. Marwick et al. (22) in a recent study used a maximal
adenosine infusion rate of 180 g/kg per min; the sensitivity of
adenosine echocardiography was 58% in patients without
previous myocardial infarction when 50% diameter stenosis
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was used to deﬁne signiﬁcant disease. Their low sensitivity,
compared with our results with a higher dose, may be ex-
plained by their discontinuation of adenosine infusion at
submaximal doses in 27 patients (28%) because of side effects
of the drug. Therefore, they achieved only submaximal vaso-
dilation in nearly one third of their patients. Tawa et al. (21)
reported an overall sensitivity of high dose (170 g/kg per min)
adenosine echocardiography of 87%, which is comparable to
our ﬁndings. Although the quest for the ideal stress test
certainly continues, the present data suggest that the high dose
adenosine regimen should probably be adopted, at least for
pharmacologic stress echocardiography testing. The same con-
clusion does not necessarily apply to other forms of perfusion
imaging, in which the diagnostic target is ﬂow maldistribution
rather than true ischemia.
Study limitations. Our study group was rather small, con-
sisting primarily of patients with one-vessel CAD, thus reﬂect-
ing the nonselected spectrum of coronary anatomy observed in
our institution. However, the Achilles heel of adenosine stress
is exactly its low sensitivity for one-vessel CAD, the most
important condition to be evaluated with a novel dose regimen.
The Belgrade University Institute for cardiovascular diseases is
a tertiary care referral center for coronary angioplasty, so our
study patients had a high probability of CAD and may not fully
represent patients seen in primary and secondary care centers.
Most of our patients were studied while they were receiving
antianginal therapy. Antianginal drugs and especially beta-
adrenergic blocking agents greatly reduce the sensitivity of
vasodilator stress echocardiography (23,24). However, with-
drawal of therapy is always impractical, can be dangerous and
is not standard practice in our institution. The evaluation of
patients receiving active treatment is therefore more likely to
reﬂect the situation encountered in everyday cardiology prac-
tice.
The interpretation of digitally acquired echocardiography
images was subjective and semiquantitative. Although this is
the state of the art method in stress echocardiography, it is
known to suffer from considerable interobserver variability
especially between observers without experience in joint read-
ing (25). However, in our study two independent observers
reviewed all the studies without knowledge of angiographic
ﬁndings; in addition, digitally acquired images were randomly
mixed before interpretation, avoiding a possible bias toward
assessing more dyssynergy with higher doses. We therefore
believe that the limitations of the study do not detract from its
main conclusions.
Conclusions. Wilson et al. (10) emphasized that the aden-
osine infusion of 140 g/kg per min in humans may not
produce absolutely maximal vasodilation in the subepicardial
myocardium in all patients and that higher infusion rates may
possibly cause maximal hyperemia. In light of this observation,
we increased the adenosine dose to 200 g/kg per min in
patients who had negative stress echocardiography test results
with the standard dose of 140 g/kg per min. Our results
suggest that the intravenous infusion of a high adenosine dose
(200 g kg per min) can improve the sensitivity of the
adenosine stress test for detecting CAD, particularly when
dyssynergy, and therefore ischemia, is the diagnostic end point.
This improvement can be attributed mainly to increased
detection of milder forms of CAD, such as one-vessel disease.
Furthermore, the increase in sensitivity was not accompanied
by a signiﬁcant loss in speciﬁcity or deterioration in safety
proﬁle. We believe that the use of higher adenosine doses will
aid in obtaining more reliable results with adenosine echocar-
diography, but this view needs to be validated in large scale
studies.
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